Dicerna Pharmaceuticals
Latest round
- Series C
Last raised
- Aug 2013
Total raised
- $105M
Investors
- 9
About Dicerna Pharmaceuticals
Dicerna Pharmaceuticals, Inc.Dicerna Pharmaceuticals, Inc. was founded in 2007 and is based in Lexington, US. The company is engaged in the development of RNA interference (RNAi) therapies, which aim to silence genes associated with various diseases. The company has completed a total of 8 deals to date, with the most recent deal occurring on January 29, 2014.Dicerna Pharmaceuticals focuses on developing RNA interference (RNAi) therapies that target specific genes involved in disease processes. Their innovative approach is designed to provide precise treatments for conditions such as rare genetic diseases and various forms of cancer. The company is focused on launching new products targeting rare genetic disorders and cancer therapies in the coming years. Additionally, Dicerna is aiming to expand its market reach, particularly in North America and Europe, by leveraging partnerships and collaborations with healthcare providers. The funds from the recent Trade Sale will support these initiatives, enabling Dicerna to enhance its research capabilities and accelerate product development.
Who invested in Dicerna Pharmaceuticals
9 investors across 4 rounds
See all investors in Dicerna Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Dicerna Pharmaceuticals
Who invested in Dicerna Pharmaceuticals?
Dicerna Pharmaceuticals has 9 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Dicerna Pharmaceuticals raised?
Dicerna Pharmaceuticals has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Dicerna Pharmaceuticals last raise money?
Dicerna Pharmaceuticals's most recent round on record is a Series C, in Aug 2013.
What does Dicerna Pharmaceuticals do?
Dicerna Pharmaceuticals is a biotechnology company.
Where is Dicerna Pharmaceuticals headquartered?
Dicerna Pharmaceuticals is headquartered in Lexington, US.
Which VCs invest in companies like Dicerna Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Dicerna Pharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Dicerna Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.